Company Data
Adaptive Biotechnologies Corporation
Ticker
ADPT
Current Price
$8.33 -2.23%
Market Cap
$1.2B
Price Target
Refer to Report
Volume
2.0M
52wk Range
$2.28 - $8.56
Overview
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.